A thirty-year analysis shows that anemia drugs produced by Amgen Inc. and Johnson & Johnson raise the risk of leukemia incidence.
The following drugs are implicated in this study: Aranesp and Epogen (by Amgen Inc.), and Procrit (by Johnson & Johnson).
In addition, the steroid danazol was linked to higher risk of leukemia.